Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi +3 more
wiley +1 more source
Advancing the impact of research through a dissemination-focused special interest group. [PDF]
Gustavson AM +3 more
europepmc +1 more source
European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development. [PDF]
Monné Rodríguez JM +11 more
europepmc +1 more source
The history of the Irish Nursing Research Interest Group (INRIG) 1976-2004
The Irish Nursing Research Interest Group (INRIG) committee members are pleased to present this publication entitled The History of the Irish Nursing Research Interest Group 1976-2004, which documents the history of INRIG from its inception in 1976 ...
Irish Nursing Research Interest Group (INRIG)
core
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Report on vasculitis special interest group [PDF]
R A, Watts, D G, Scott
openaire +2 more sources
European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver disease. [PDF]
Mann JP +30 more
europepmc +1 more source
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance. [PDF]
Yue QY.
europepmc +1 more source
SPG4 and Dementia: Expanding the Clinical Spectrum
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza +19 more
wiley +1 more source
Reaching a Consensus on the Definition of Telerehabilitation: World Federation of Neurorehabilitation Telerehabilitation Special Interest Group. [PDF]
Hill AJ +6 more
europepmc +1 more source

